UNSPSC 51284014: Oxytetracycline

This classification denotes a tetracycline antibiotic with the molecular formula C22H24N2O9.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X20I9EN955, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo- but generally known as oxytetracycline, which bears US NIH Compound Identifier 5280972. European Medicines Agency schedules Oxytetracycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09579MIG.

UNSPSC 51284014 Oxytetracycline, a Commodity code, shows significant mismatch between its nominal scope and recent state and local solicitation activity. The code nominally covers a specific antibiotic pharmaceutical, yet the four most recent opportunities tagged to it solicited naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals with OTC products—none of which are oxytetracycline. State and local procurement offices are using this code as a catch-all taxonomy for pharmaceutical and medical supply procurement broadly, not for the narrow product line the code nominally describes. The issuing bodies span state health and human services agencies, county health departments, municipal fire departments, and multistate cooperative purchasing alliances, indicating that pharmaceutical and medical supply procurement occurs across all levels of state and local government.

Recent activity centers on Florida, Texas, Minnesota, and Oregon. The Seminole County, Florida IFB (IFB60459723LAS, response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health delivery. The Texas Health and Human Services Commission issued an RFI (HHS0017013, response deadline April 3, 2026) to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The City of Tampa's IFB (26P00145, response due March 13, 2026) solicited 169 line items of medical and first aid supplies for its fire department rescue division under a sheltered Small Local Business Enterprise set-aside with a 5 percent bid discount capped at $10,000 and an estimated contract value of $700,000. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, including Oregon, with wholesaler distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson. The code shows no dedicated recent oxytetracycline solicitations; vendors pursuing opportunities here should treat the taxonomy as unreliable and focus instead on the broad pharmaceutical and medical supply procurement signals the recent opportunities actually represent.